NexgenRX Inc. Capital Reinvestment Ratio
NexgenRX Inc. capital reinvestment ratio. NexgenRX Inc. (NXG) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$880.82K) in capital expenditures (CA$18.07K). Check NexgenRX Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NexgenRX Inc. (2013–2024)
Capital reinvestment ratio of NexgenRX Inc. from 2013 to 2024. This chart tracks NexgenRX Inc.'s Capital Reinvestment Ratio across 8 annual periods. Also explore NXG shareholders equity momentum to track the company's year-over-year net asset growth rate.
NexgenRX Inc. Capital Reinvestment Ratio by Year (2013–2024)
NexgenRX Inc. capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see how efficiently does NexgenRX Inc. generate cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CA$1.15 Million | CA$317.69K | ▲ +42.0% |
| 2023 | 0.19x | CA$1.28 Million | CA$248.41K | ▼ -46.7% |
| 2022 | 0.36x | CA$1.07 Million | CA$388.81K | ▲ +1002.2% |
| 2021 | 0.03x | CA$3.82 Million | CA$126.55K | ▼ -27.3% |
| 2020 | 0.05x | CA$2.65 Million | CA$120.74K | ▼ -6.3% |
| 2019 | 0.05x | CA$1.05 Million | CA$50.78K | ▼ -93.3% |
| 2016 | 0.72x | CA$490.96K | CA$355.00K | ▲ +1084.7% |
| 2013 | 0.06x | CA$774.08K | CA$47.24K | — |